Sanofi India LimitedSanofi India LimitedSanofi India Limited

Sanofi India Limited

No trades
No trades

Compare with Sanofi India Limited


Market capitalization
‪77.84 B‬INR
134.5INR
‪3.27 B‬INR
‪18.36 B‬INR
‪8.48 M‬
Beta (1Y)
0.74
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪1.1 K‬
Change (1Y)
+106+10.70%
Revenue / Employee (1Y)
‪16.73 M‬INR
Net income / Employee (1Y)
‪2.98 M‬INR

Details


CEO
Deepak Arora
Headquarters
Mumbai
Founded
1956
IPO date
Nov 28, 1994
ISIN
INE058A01010
FIGI
BBG000CSRP45
Identifiers
ISIN INE058A01010
CFI code
ESVUFN
Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. The firm offers its products under the following brands: AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Amaryl, Renvela Sachets, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trenta, Vinlep, and Zolineg. The entity also focuses on therapeutic areas, which include diabetes, cardiology, consumer healthcare, hospital, central nervous system, and antihistamines. It operates through the following geographical segments: India, Singapore, and Others. The company was founded on May 2, 1956 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of SANOFI is 3,409.4 INR — it has increased by 0.77% in the past 24 hours. Watch Sanofi India Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Sanofi India Limited stocks are traded under the ticker SANOFI.
SANOFI stock has risen by 1.40% compared to the previous week, the month change is a 1.62% rise, over the last year Sanofi India Limited has showed a −42.35% decrease.
We've gathered analysts' opinions on Sanofi India Limited future price: according to them, SANOFI price has a max estimate of 5,550.00 INR and a min estimate of 3,520.00 INR. Watch SANOFI chart and read a more detailed Sanofi India Limited stock forecast: see what analysts think of Sanofi India Limited and suggest that you do with its stocks.
SANOFI reached its all-time high on Sep 6, 2024 with the price of 7,600.0 INR, and its all-time low was 377.0 INR and was reached on Oct 27, 2008. View more price dynamics on SANOFI chart.
See other stocks reaching their highest and lowest prices.
SANOFI stock is 2.11% volatile and has beta coefficient of 0.74. Track Sanofi India Limited stock price on the chart and check out the list of the most volatile stocks — is Sanofi India Limited there?
Today Sanofi India Limited has the market capitalization of ‪77.84 B‬, it has increased by 2.05% over the last week.
Yes, you can track Sanofi India Limited financials in yearly and quarterly reports right on TradingView.
Sanofi India Limited is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
Sanofi India Limited revenue for the last quarter amounts to ‪4.72 B‬ INR, despite the estimated figure of ‪4.83 B‬ INR. In the next quarter, revenue is expected to reach ‪4.37 B‬ INR.
SANOFI net income for the last quarter is ‪1.03 B‬ INR, while the quarter before that showed ‪617.00 M‬ INR of net income which accounts for 0.00% change. Track more Sanofi India Limited financial stats to get the full picture.
Sanofi India Limited dividend yield was 3.01% in 2025, and payout ratio reached 86.71%. The year before the numbers were 1.91% and 65.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 22, 2026, the company has ‪1.1 K‬ employees. See our rating of the largest employees — is Sanofi India Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanofi India Limited EBITDA is ‪4.68 B‬ INR, and current EBITDA margin is 27.65%. See more stats in Sanofi India Limited financial statements.
Like other stocks, SANOFI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi India Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanofi India Limited technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanofi India Limited stock shows the sell signal. See more of Sanofi India Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.